Dalpiciclib 125mg: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
8
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast cancer | 2 |
| Breast Diseases | 1 |
| Breast Neoplasms | 1 |
| CDK4/6 Inhibitor | 1 |
| Dalpiciclib | 1 |
| Endocrine Breast Diseases | 1 |
| HR Positive HER2 Negative Advanced Breast Cancer | 1 |
| HR+/HER2- Breast Cancer | 1 |
Recruiting trials involving Dalpiciclib 125mg
- Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
- Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Common questions
How many recruiting trials involve Dalpiciclib 125mg?
2 recruiting trials across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.